scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.M004164200 |
P698 | PubMed publication ID | 11024046 |
P50 | author | J. Evan Sadler | Q42645712 |
P2093 | author name string | Vindigni A | |
Li CQ | |||
Wardell MR | |||
P2860 | cites work | Protease-activated receptor 3 is a second thrombin receptor in humans | Q24310957 |
Identification of three tyrosine residues of glycoprotein Ib alpha with distinct roles in von Willebrand factor and alpha-thrombin binding | Q24314966 | ||
Cloning and characterization of human protease-activated receptor 4 | Q24322941 | ||
Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation | Q24337851 | ||
Peptide exosite inhibitors of factor VIIa as anticoagulants | Q27622190 | ||
The molecular environment of the Na+ binding site of thrombin | Q27736084 | ||
A dual thrombin receptor system for platelet activation | Q28280578 | ||
Evidence for allosteric linkage between exosites 1 and 2 of thrombin | Q73770372 | ||
Characterization of the initial alpha-thrombin interaction with glycoprotein Ib alpha in relation to platelet activation | Q74088680 | ||
Platelet responses to compound interactions with thrombin | Q78021240 | ||
Identification of the disulphide bonds in human platelet glycocalicin | Q34131135 | ||
An allosteric switch controls the procoagulant and anticoagulant activities of thrombin | Q34172057 | ||
Structure of the Ca2+-free GLA domain sheds light on membrane binding of blood coagulation proteins | Q34304306 | ||
Regulation of thrombin activity by antithrombin and heparin | Q34321620 | ||
Structure and function of platelet membrane glycoproteins Ib and V. Effects of leukocyte elastase and other proteases on platelets response to von Willebrand factor and thrombin | Q34562281 | ||
Interaction of coagulation factor Xa with human platelets | Q35053163 | ||
Molecular mapping of the heparin-binding exosite of thrombin | Q35478768 | ||
High-affinity alpha-thrombin binding to platelet glycoprotein Ib alpha: identification of two binding domains | Q35569261 | ||
Platelet procoagulant activity: physiological significance and mechanisms of exposure | Q36928487 | ||
Reduced thrombin binding and aggregation in Bernard-Soulier platelets | Q37052459 | ||
Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin | Q37565691 | ||
Tyrosine sulfation of the glycoprotein Ib-IX complex: identification of sulfated residues and effect on ligand binding | Q38302282 | ||
Platelet physiology and abnormalities of platelet function (first of two parts). | Q39944486 | ||
A player of many parts: the spotlight falls on thrombin's structure. | Q40893212 | ||
Effective electrostatic charge of coagulation factor X in solution and on phospholipid membranes: implications for activation mechanisms and structure-function relationships of the Gla domain | Q41052593 | ||
Thrombin interaction with platelet membrane glycoprotein Ib. | Q41112678 | ||
Molecular mechanisms of thrombin function | Q41642235 | ||
Thrombin Receptors of Human Platelets: Thrombin Binding and Antithrombin Properties of Glycoprotein I | Q41724872 | ||
Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects. | Q41918902 | ||
The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1 | Q44595454 | ||
Thrombin is a Na(+)-activated enzyme | Q45261449 | ||
Expression of platelet glycoprotein (GP) V in heterologous cells and evidence for its association with GP Ib alpha in forming a GP Ib-IX-V complex on the cell surface. | Q45962782 | ||
Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin | Q47262509 | ||
Energetics of thrombin-thrombomodulin interaction. | Q52262163 | ||
Role of the thrombin receptor in development and evidence for a second receptor. | Q52519548 | ||
Quantitative evaluation of the contribution of ionic interactions to the formation of the thrombin-hirudin complex. | Q52523504 | ||
Interaction of von Willebrand Factor Domain A1 with Platelet Glycoprotein Ibα-(1–289) | Q60265920 | ||
Effect of heparin on the interaction between thrombin and hirudin | Q69467938 | ||
Thrombin interactions with platelet membrane proteins | Q70173281 | ||
Chemical compensation in macromolecular bridge-binding to thrombin | Q70622059 | ||
Release of fibrinopeptides by the slow and fast forms of thrombin | Q71010220 | ||
Determinants of thrombin receptor cleavage. Receptor domains involved, specificity, and role of the P3 aspartate | Q71869446 | ||
The Na+ Binding Site of Thrombin | Q72054938 | ||
A simple activity assay for thrombin and hirudin | Q72871873 | ||
Preparation and application of a photoreactive thrombin analog: binding to human platelets | Q72908042 | ||
The Asp(272)-Glu(282) region of platelet glycoprotein Ibalpha interacts with the heparin-binding site of alpha-thrombin and protects the enzyme from the heparin-catalyzed inhibition by antithrombin III | Q73413882 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 6161-6168 | |
P577 | publication date | 2000-10-09 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Platelet glycoprotein Ib alpha binds to thrombin anion-binding exosite II inducing allosteric changes in the activity of thrombin. | |
P478 | volume | 276 |
Q31130787 | A novel class of small functional peptides that bind and inhibit human alpha-thrombin isolated by mRNA display |
Q36788507 | Allosterism-based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα-binding and heparin-binding site of thrombin. |
Q77296407 | Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II |
Q27667770 | Binding of -thrombin to surface-anchored platelet glycoprotein Ib sulfotyrosines through a two-site mechanism involving exosite I |
Q33480624 | Biophysical investigation of GpIbalpha binding to thrombin anion binding exosite II. |
Q36053189 | Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function |
Q78862527 | Establishing the inhibitory effects of bradykinin on thrombin |
Q84509369 | Evolution of thrombin and other hemostatic proteases by survey of protochordate, hemichordate, and echinoderm genomes |
Q36884329 | Exosites in the substrate specificity of blood coagulation reactions |
Q35349699 | Fast photochemical oxidation of proteins for epitope mapping |
Q44518940 | Fibrinogen gamma' chain binds thrombin exosite II. |
Q27680808 | GpIbα Interacts Exclusively with Exosite II of Thrombin |
Q61943901 | Inhibition of thrombin activity by prothrombin activation fragment 1.2 |
Q41934357 | Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII. |
Q34333809 | Platelet glycoproteins and their role in diseases |
Q38530486 | Structural transitions during prothrombin activation: On the importance of fragment 2 |
Q42194253 | Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains |
Q34264585 | Substantial non-electrostatic forces are needed to induce allosteric disruption of thrombin's active site through exosite 2. |
Q37426582 | Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin. |
Q28236023 | Targeting the GPIbα binding site of thrombin to simultaneously induce dual anticoagulant and antiplatelet effects |
Q45063820 | Thrombin activation of factor XI on activated platelets requires the interaction of factor XI and platelet glycoprotein Ib alpha with thrombin anion-binding exosites I and II, respectively |
Q34291931 | Thrombin domains: structure, function and interaction with platelet receptors |
Q53061821 | Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib |
Search more.